Technical Analysis for IPHA - Innate Pharma S.A.

Grade Last Price % Change Price Change
grade C 7.4 -4.27% -0.33
IPHA closed down 4.27 percent on Friday, February 14, 2020, on 36 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Flat
Historical IPHA trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish -4.27%
New Uptrend Bullish -4.27%
180 Bullish Setup Bullish Swing Setup -4.27%
Pocket Pivot Bullish Swing Setup -4.27%
Narrow Range Bar Range Contraction -4.27%
NR7 Range Contraction -4.27%
Stochastic Reached Overbought Strength -4.27%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Medicine Biopharmaceutical Cancer Medical Specialties Immunology Antibodies Immunotherapy Immune System Antibody Cancer Treatment Inflammatory Diseases Monoclonal Antibody

Is IPHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 8.24
52 Week Low 5.61
Average Volume 37,051
200-Day Moving Average 0.00
50-Day Moving Average 6.88
20-Day Moving Average 7.35
10-Day Moving Average 7.42
Average True Range 0.25
ADX 25.06
+DI 32.01
-DI 23.31
Chandelier Exit (Long, 3 ATRs ) 7.03
Chandelier Exit (Short, 3 ATRs ) 7.58
Upper Bollinger Band 7.85
Lower Bollinger Band 6.86
Percent B (%b) 0.55
BandWidth 13.57
MACD Line 0.17
MACD Signal Line 0.16
MACD Histogram 0.0052
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.93
Resistance 3 (R3) 7.98 7.87 7.84
Resistance 2 (R2) 7.87 7.73 7.84 7.81
Resistance 1 (R1) 7.63 7.65 7.58 7.58 7.78
Pivot Point 7.52 7.52 7.49 7.49 7.52
Support 1 (S1) 7.28 7.38 7.23 7.23 7.02
Support 2 (S2) 7.17 7.30 7.14 6.99
Support 3 (S3) 6.93 7.17 6.96
Support 4 (S4) 6.88